This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a ...

GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

AZ and GSK have their global headquarters and R&D bases in the UK, and have been expanding the number of UK alliances in recent years. Johnson & Johnson doesn't have its own R&D base in the UK ...

GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug development, Ashleigh Furlong of Bloomberg reports.

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

Until four years ago, GSK stock was my family’s biggest shareholding. By spring 2021, we’d been shareholders of this UK biopharma giant for over three decades. This happened because my wife joined ...

The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the drug’s first approval worldwide since it was pulled from the US and other ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...